(PCVX) Vaxcyte - Performance -57.2% in 12m
PCVX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
11.68%
#23 in Peer-Group
Rel. Strength
7.73%
#6853 in Stock-Universe
Total Return 12m
-57.19%
#140 in Peer-Group
Total Return 5y
12.12%
#31 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 117.93 USD |
| 52 Week Low | 28.04 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 46.34 |
| Buy/Sell Signal +-5 | 0.49 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PCVX (-57.2%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PCVX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PCVX
| Total Return (including Dividends) | PCVX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.94% | 2.27% | 4.52% |
| 3 Months | 2.20% | 6.30% | 10.43% |
| 12 Months | -57.19% | -10.68% | 14.67% |
| 5 Years | 12.12% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | PCVX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -82.3% | 5.5% | 79.1% |
| 3 Months | 45.6% | 74.3% | 94.2% |
| 12 Months | -64% | -84.7% | 44.4% |
| 5 Years | 69.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th38.00 | -8.03% | -10.00% |
| 3 Month | %th47.50 | -3.86% | -7.45% |
| 12 Month | %th31.00 | -52.07% | -62.67% |
| 5 Years | %th85.00 | 51.78% | -46.41% |
FAQs
Does Vaxcyte (PCVX) outperform the market?
No,
over the last 12 months PCVX made -57.19%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months PCVX made 2.20%, while XBI made 6.30%.
Performance Comparison PCVX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PCVX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.2% | -10.5% | -66.7% | -72% |
| US NASDAQ 100 | QQQ | -4.7% | -10.6% | -68% | -71% |
| German DAX 40 | DAX | -3.5% | -4.9% | -78.2% | -86% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.2% | -10.1% | -67.7% | -75% |
| Hongkong Hang Seng | HSI | -3.4% | -12% | -84.5% | -93% |
| India NIFTY 50 | INDA | -5.3% | -8.3% | -65% | -57% |
| Brasil Bovespa | EWZ | -6.3% | -13.5% | -89.6% | -70% |
PCVX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5.8% | -12% | -71.8% | -85% |
| Consumer Discretionary | XLY | -4.6% | -8% | -59.5% | -78% |
| Consumer Staples | XLP | -4.2% | -5.5% | -66.3% | -68% |
| Energy | XLE | -4% | -10.2% | -60.7% | -54% |
| Financial | XLF | -5.5% | -9.6% | -70.5% | -87% |
| Health Care | XLV | -5.6% | -9.4% | -60.7% | -53% |
| Industrial | XLI | -5.4% | -10% | -73.9% | -82% |
| Materials | XLB | -6.1% | -10.2% | -69.8% | -63% |
| Real Estate | XLRE | -2% | -6.6% | -65.6% | -71% |
| Technology | XLK | -4.9% | -13.9% | -69% | -68% |
| Utilities | XLU | -3.8% | -6.3% | -69.4% | -82% |
| Aerospace & Defense | XAR | -5.8% | -13.2% | -85.2% | -106% |
| Biotech | XBI | -2.5% | -8.2% | -51.2% | -47% |
| Homebuilder | XHB | -7.7% | -16.4% | -60.2% | -62% |
| Retail | XRT | -6.2% | -10.4% | -61% | -67% |
PCVX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.6% | -12.2% | -56.6% | -48% |
| Natural Gas | UNG | 3.7% | 4.5% | -49.3% | -48% |
| Gold | GLD | -3.8% | -4.6% | -85.8% | -100% |
| Silver | SLV | -3.7% | -9.6% | -82% | -79% |
| Copper | CPER | -6.2% | -9.9% | -85.1% | -72% |
PCVX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -4.2% | -9.4% | -62.9% | -59% |
| iShares High Yield Corp. Bond | HYG | -3.4% | -7.2% | -64.6% | -67% |